The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective

Hangjian Wu; Cristina Fernandez-Garcia; Nicole O’Connor; Oleta Williams; Sola Akinbolade; Ayomikun Ogunyemi; Sonia Garcia Gonzalez-Moral; Fiona Beyer; Nick Meader; Stephen Rice

doi:10.1007/s40273-025-01570-4

The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective

Hangjian Wu
, Cristina Fernandez-Garcia
, Nicole O’Connor
, Oleta Williams
, Sola Akinbolade
, Ayomikun Ogunyemi
, Sonia Garcia Gonzalez-Moral
, Fiona Beyer
, Nick Meader
, Stephen Rice

Newcastle University

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	263-266
Number of pages	4
Journal	PharmacoEconomics
Volume	44
Issue number	3
DOIs	https://doi.org/10.1007/s40273-025-01570-4
State	Published - Mar 2026
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1007/s40273-025-01570-4

Cite this

Wu, H., Fernandez-Garcia, C., O’Connor, N., Williams, O., Akinbolade, S., Ogunyemi, A., Gonzalez-Moral, S. G., Beyer, F., Meader, N., & Rice, S. (2026). The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective. PharmacoEconomics, 44(3), 263-266. https://doi.org/10.1007/s40273-025-01570-4

Wu, H, Fernandez-Garcia, C, O’Connor, N, Williams, O, Akinbolade, S, Ogunyemi, A, Gonzalez-Moral, SG, Beyer, F, Meader, N & Rice, S 2026, 'The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective', PharmacoEconomics, vol. 44, no. 3, pp. 263-266. https://doi.org/10.1007/s40273-025-01570-4

@article{e85c2c3aecc74b33a05335a4f43d0d6a,

title = "The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective",

author = "Hangjian Wu and Cristina Fernandez-Garcia and Nicole O{\textquoteright}Connor and Oleta Williams and Sola Akinbolade and Ayomikun Ogunyemi and Gonzalez-Moral, \{Sonia Garcia\} and Fiona Beyer and Nick Meader and Stephen Rice",

year = "2026",

month = mar,

doi = "10.1007/s40273-025-01570-4",

language = "English",

volume = "44",

pages = "263--266",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd.",

number = "3",

}

TY - JOUR

T1 - The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation

T2 - Evidence Assessment Group Perspective

AU - Wu, Hangjian

AU - Fernandez-Garcia, Cristina

AU - O’Connor, Nicole

AU - Williams, Oleta

AU - Akinbolade, Sola

AU - Ogunyemi, Ayomikun

AU - Gonzalez-Moral, Sonia Garcia

AU - Beyer, Fiona

AU - Meader, Nick

AU - Rice, Stephen

PY - 2026/3

Y1 - 2026/3

UR - https://www.scopus.com/pages/publications/105027125769

UR - https://www.scopus.com/pages/publications/105027125769#tab=citedBy

U2 - 10.1007/s40273-025-01570-4

DO - 10.1007/s40273-025-01570-4

M3 - Comment/debate

C2 - 41514119

AN - SCOPUS:105027125769

SN - 1170-7690

VL - 44

SP - 263

EP - 266

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 3

ER -

The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this